The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:2164-2169, December 2006
doi: 10.1176/appi.ajp.163.12.2164
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Csernansky, J. G.
* Articles by Morris, J. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Csernansky, J. G.
* Articles by Morris, J. C.
Related Collections
* Neuroendocrinology
* Alzheimer's Disease

Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia

John G. Csernansky, M.D., Hongxin Dong, Ph.D., Anne M. Fagan, Ph.D., Lei Wang, Ph.D., Chengjie Xiong, Ph.D., David M. Holtzman, M.D., and John C. Morris, M.D.

OBJECTIVE: Studies of subjects with dementia of the Alzheimer type have reported correlations between increases in activity of the hypothalamic-pituitary-adrenal (HPA) axis and hippocampal degeneration. In this study, the authors sought to determine whether increases in plasma cortisol, a marker of HPA activity, were associated with clinical and cognitive measures of the rate of disease progression in subjects with Alzheimer-type dementia. METHOD: Thirty-three subjects with very mild and mild Alzheimer-type dementia and 21 subjects without dementia were assessed annually for up to 4 years with the Clinical Dementia Rating scale and a battery of neuropsychological tests. Plasma was obtained at 8 a.m. on a single day and assayed for cortisol. Rates of change over time in the clinical and cognitive measures were derived from growth curve models. RESULTS: In the subjects with dementia, but not in those without dementia, higher plasma cortisol levels were associated with more rapidly increasing symptoms of dementia and more rapidly decreasing performance on neuropsychological tests associated with temporal lobe function. No associations were observed between plasma cortisol levels and clinical and cognitive assessments obtained at the single assessment closest in time to the plasma collection. CONCLUSIONS: Higher HPA activity, as reflected by increased plasma cortisol levels, is associated with more rapid disease progression in subjects with Alzheimer-type dementia.




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
C. A. Reyes-Ortiz, I. M. Berges, M. A. Raji, H. G. Koenig, Y.-F. Kuo, and K. S. Markides
Church Attendance Mediates the Association Between Depressive Symptoms and Cognitive Functioning Among Older Mexican Americans
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 480 - 486.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
E. J. Lenze and B. H. Mulsant
Biomarkers in Geriatric Psychiatry
Am J Geriatr Psychiatry, October 1, 2007; 15(10): 827 - 831.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-E. Kang, J. R. Cirrito, H. Dong, J. G. Csernansky, and D. M. Holtzman
Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity
PNAS, June 19, 2007; 104(25): 10673 - 10678.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org